Skip to Main Content

Creating life sciences firms may be risky, but the appetite of investors shows no sign of waning.

Third Rock Ventures, the Boston venture capital firm, said Thursday that it has raised $770 million from investors for its fifth and latest fund. The company has collected a total of $2.7 billion for life sciences businesses since its inception in 2007.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!